Oncology Anxiety

It doesn't matter how many years out it is but a visit to the oncologist always is uncomfortable. Its unsettling. Its alarming. Its distressing. Its ominous. I can't come up with enough words to describe it. And its today.I had my annual mammogram back in July and then saw my surgeon. Technically, I am supposed to be followed by my breast surgeon for life after treatment ends. But his office was difficult to schedule with so after a few years, I dumped him. I also dumped my rads onc a few years back. She was pretty useless too. She used to tell me things like I should stop working so my husband could support me since I had had cancer. Not good medical advice.I was originally supposed to see my oncologist after my mammogram but the surgeon took over. I had a momentary cancer freakout last winter and ended up at my surgeon's office. He told me his office would now start following me after my mammograms and had an appointment with his office scheduled for the same day. So my oncologist asked me if I wanted to see her office on a different date - to spread out cancer follow up appropriately.Anyway, so I get to go see my onc's NP today. I am still on (or back on) femara for another couple of years. So today I am a little unsettled, alarmed, distressed, etc. You never know when you see an oncologist what they might find....Damn.
Source: Caroline's Breast Cancer Blog - Category: Cancer & Oncology Tags: breast cancer treatment doctor appointments follow up oncologist Source Type: blogs

Related Links:

This appeared a few days ago.Google AI system beats doctors in detection tests for breast cancerHannah KuchlerJan 2, 2020 — 3.19pmNew York | Google Health has developed a system that can identify breast cancer more accurately than radiologists, in the latest sign that artificial intelligence could improve early detection of disease in images.In a paper published in the scientific journal Nature, experts from Google H ealth, Alphabet’s DeepMind unit, and UK and US universities showed the AI model reduced both false positives, in which patients are wrongly told they have cancer, as well as false negatives, where ...
Source: Australian Health Information Technology - Category: Information Technology Authors: Source Type: blogs
AbstractBackgroundTo date, 38 states have enacted dense breast notification (DBN) laws mandating that mammogram reports include language informing women of risks related to dense breast tissue.ObjectiveNationally representative survey to assess the association between residing in a state with a DBN law and women ’s awareness and knowledge about breast density, and breast cancer anxiety.DesignInternet survey conducted in 2018 with participants in KnowledgePanel ®, an online research panel.ParticipantsEnglish-speaking US women ages 40 –59 years without a personal history of breast cancer who had received...
Source: Journal of General Internal Medicine - Category: Internal Medicine Source Type: research
Publication date: Available online 23 December 2019Source: Journal of Cancer PolicyAuthor(s): Athena Michaelides, Constantina ConstantinouAbstractBreast cancer is the second most common cancer diagnosed worldwide and the leading cause of cancer death in women. In the past years, efforts have been made to develop psychoeducation programmes targeting the prevention of breast cancer via educating the general public. These programmes placed emphasis on risk reducing behaviours and on promoting Breast Self-Examination and screening via mammography, to aid in the early identification of pathological findings. In parallel, effort...
Source: Journal of Cancer Policy - Category: Cancer & Oncology Source Type: research
DiscussionBased on previously published retrospective studies, we expect to demonstrate in this prospective multicenter randomized controlled trial, that using CESM as a primary work-up tool in women recalled from breast cancer screening is a more accurate, cost-effective, and patient-friendly strategy.Trial registration Netherlands Trial Register,NL6413/NTR6589. Registered on 6 July, 2017.
Source: Trials - Category: Research Source Type: clinical trials
This study has implications for cancer risk communication and will offer evidence on the potential of generalizable educational strategies for delivering information on breast density to Latinas in limited-resource settings.Trial registrationClinicalTrials.gov,NCT02910986. Registered on 21 September 2016.Items from the WHO Trial Registration Data Set can be found in this protocol.
Source: Trials - Category: Research Source Type: clinical trials
Conclusion: In conclusion, women with breast cancer may attempt to use CAM due to hopelessness. Therefore, in the course of medical treatment of patients, CAM practices should be questioned, they should be provided counseling and if necessary, referred for psychological support.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Source Type: research
Conclusions: Fat-grafting sequelae may lead to early unplanned invasive and noninvasive procedures initiated by a variety of providers. In this study, fat grafting had no impact on local recurrence rate. As use of fat grafting grows, communication among breast cancer care providers and enhanced patient and caregiver education will be increasingly important in optimizing the multidisciplinary evaluation and monitoring of palpable breast lesions. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
Source: Plastic and Reconstructive Surgery - Category: Cosmetic Surgery Tags: Breast: Original Articles Source Type: research
AbstractPurpose of ReviewThe purpose of this review is to examine the most recent data and guidelines regarding screening for breast cancer in average risk women.Recent FindingsThe differing recommendations for screening reflect differences in value judgements between the benefits (decreased cancer-related death and morbidity) and the harms (potential for overdiagnosis, false positives, false negatives, anxiety, and cost of care) of breast cancer screening.SummaryThere are multiple organizations with recommendations for breast cancer screening in women at average risk. All organizations recommend mammography to screen for ...
Source: Current Breast Cancer Reports - Category: Cancer & Oncology Source Type: research
ConclusionMammographic and ultrasound findings can highly suggest a diagnosis of granulomatous mastitis in an appropriate clinical context.
Source: Journal of Ultrasound - Category: Radiology Source Type: research
The Food and Drug Administration (FDA) wants to require mammogram providers to tell women if they have a common risk factor for breast cancer. The proposal, released Wednesday, would be the FDA’s first update to mammography regulations in more than 20 years, according to a statement from the agency. Among other proposed changes, the policy would require mammography providers to inform patients who undergo the breast cancer screening test if they have dense breast tissue, which may both warp the results of a mammogram by obscuring signs of cancer, and increase the risk of developing breast cancer in the first place. ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Cancer onetime Source Type: news
More News: Anxiety | Blogging | Breast Cancer | Cancer | Cancer & Oncology | Mammography